Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	1.84B
Revenue (ttm)	1.23B
Net Income (ttm)	376.65M
Shares Out	22.75M
EPS (ttm)	66.96
PE Ratio	1.21
Forward PE	n/a
Dividend	4.00 (4.95%)
Ex-Dividend Date	Nov 13, 2024

Volume	83,538
Average Volume	239,386
Open	79.55
Previous Close	79.55
Day's Range	80.04 - 81.89
52-Week Range	31.00 - 106.96
Beta	0.25
RSI	68.65
Earnings Date	May 14, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2024, EGX:MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.